METTL3 and breast cancer: These data further suggested that blocking miR-338-3p upregulation by interfering its METTL3/m6A/DGCR8 maturation mechanism was a feasible strategy to prevent the adverse transmitting of miR-338-3p between breast cancer cells and cardiomyocytes that aggravated DOXIC.